263 - MANAGING THE CARDIOVASCULAR CONSEQUENCES OF THE COVID-19 PANDEMIC: APPLYING EMERGING EVIDENCE IN CARDIOLOGY PRACTICE

Co-Chair(s)

• AL

  Adriana Luk, MD

  Cardiologist
  CANCARE
• MM

  Michael McDonald, MD FRCPC

  Associate Professor
  University of Toronto
  Toronto General Hospital

Presenter(s)

• 

  Nathaniel Hawkins, MBChB, MD, MPH

  Clinical Associate Professor
  University of British Columbia
  University of British Columbia
• TH

  Thao Huynh, MD MSc PhD

  Cardiologist
  McGill University Health Centre
• NJ

  Naveed Janjua, MBBS, MSc, DrPH
• 

  Michael Khoury, MD FRCPC

  Pediatric Cardiologist - Heart Function and Transplant
  CPCA
  University of Alberta

Moderator(s)

• AL

  Adriana Luk, MD

  Cardiologist
  CANCARE

Presenter(s)

• SR

  Satish Raj, MD MSCI FRCPC

  Cardiac Electrophysiologist
  University of Calgary
  University of Calgary

Administrator ( Guidelines Submission Only )(s)

• MW

  Meredith Wright, PhD

  Senior Program Advisor
  Canadian Cardiovascular Society

Planning Committee Member(s)

• 

  Nathaniel Hawkins, MBChB, MD, MPH

  Clinical Associate Professor
  University of British Columbia
  University of British Columbia
• 

  Michael Khoury, MD FRCPC

  Pediatric Cardiologist - Heart Function and Transplant
  CPCA
  University of Alberta
• AL

  Adriana Luk, MD

  Cardiologist
  CANCARE
• MM

  Michael McDonald, MD FRCPC

  Associate Professor
  University of Toronto
  Toronto General Hospital
• MW

  Meredith Wright, PhD

  Senior Program Advisor
  Canadian Cardiovascular Society

Workshop Description: Long-term cardiovascular complications following COVID-19 infection may impact an individual's quality of life and health outcomes. COVID-19 infection is associated with increased long term cardiovascular risk. Patients with long-COVID may experience a range of cardiac conditions including myocarditis, pericarditis, arrhythmias, and dysautonomia. In rare instances, mRNA COVID-19 vaccination is associated with myocarditis and/or pericarditis. This workshop will address the management of the chronic cardiovascular consequences of COVID-19 infection and mRNA COVID-19 vaccination in children and adults through a series of clinical vignettes. Early results from the Canadian Cardiovascular Society (CCS) Active Surveillance Study of Myocarditis and/or Pericarditis following mRNA COVID-19 Vaccination (MYCOVACC) as well as benefits and risks associated with mRNA COVID-19 vaccination will also be discussed. Emerging evidence will be critically evaluated to help equip clinicians with knowledge to support patient care and counselling. The session will provide opportunities for questions, discussion, and audience interaction.